Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

9:32 AM ET 6-K
Financial Results Fresenius Medical Care AG FMS

Fresenius Medical Care Q3 2026 Results: Net Income $225M, Down 31.3% YoY

Fresenius Medical Care AG reported its interim financial results for the third quarter of 2026, highlighting a reorganization of its pharmaceutical business from the Care Enablement segment to the Care Delivery segment. The report also notes the integration of administrative functions for the Value-Based Care segment into global functional areas and the ongoing implementation of a new enterprise resource planning software.

Key figure
Net income $225M · -31.3% YoY
9:32 AM ET 8-K
Financial Results Syra Health Corp SYRA

Syra Health Financial Results

Syra Health reported its third consecutive profitable quarter with record revenue of $2.6 million, a 52% increase year-over-year. The company achieved a record gross margin of 46.3% and positive net income of $0.34 million, compared to a loss in the prior year period.

Term
Q3 2026
9:28 AM ET 10-Q
Financial Results Beta Technologies, Inc. BETA ▶ Call

Beta Technologies Q3 2026 Results: Net Loss of $119M, Loss Narrows

BETA Technologies, Inc. reported a total asset base of $1.86 billion as of September 30, 2026, down from $2.11 billion at the end of 2025, primarily driven by a decrease in cash and cash equivalents. The company's accumulated deficit increased to $2.30 billion, reflecting a net loss of approximately $390 million for the first nine months of the year as it continues to invest in aircraft certification and manufacturing.

Key figure
Net loss $119M
9:25 AM ET 8-K
Financial Results Zebra Technologies Corp ZBRA

Zebra Technologies Financial Results

Zebra Technologies reported record third-quarter 2026 results with net sales increasing 22.3% to $1.61 billion, driven by strong demand for automation and the contribution of the Elo Touch acquisition. The company achieved a net income of $164 million and raised its full-year outlook while returning $75 million to shareholders through stock repurchases during the quarter.

Term
Q3 2026

“We delivered another record quarter underpinned by strong execution and broad-based demand trends with Elo Touch contributing to our double-digit growth as customers prioritize automating their frontline operations. Our efforts to strengthen memory supply, implement pricing actions and capture operating leverage enabled us to support our growth while maintaining adjusted EBITDA margin year-over-year.”

Bill Burns, Chief Executive Officer of Zebra Technologies

“We are putting our strong cash generation and balance sheet to work, investing in growth while returning capital to shareholders. We repurchased more than $640 million of shares through the first nine months of the year, reflecting our confidence in Zebra's long-term opportunity and our commitment to disciplined capital allocation.”

Nathan Winters, Chief Financial Officer of Zebra Technologies
9:22 AM ET 10-Q
Financial Results Alkermes plc. ALKS

Alkermes Q3 2026 Results: Net Income $16.3M, Down 80.3% YoY

Alkermes plc reported a significant increase in cash and cash equivalents to $631.3 million as of September 30, 2026, compared to $388.6 million at year-end 2025. The company's intangible assets grew substantially from $0.8 million to over $1.74 billion, reflecting the impact of the Avadel Acquisition and its expanded neuroscience portfolio including LUMRYZ.

Key figure
Net income $16.3M · -80.3% YoY
9:18 AM ET 8-K
Financial Results Otter Tail Corp OTTR

Otter Tail Financial Results

Otter Tail Corporation reported Q3 2026 diluted earnings per share of $1.41 and narrowed its full-year earnings guidance. The company also declared a quarterly common stock dividend of $0.5775 per share and noted that its Electric segment is advancing solar and wind repowering projects.

Term
Q3 2026

“Our team members continue to deliver on our strategic growth plan and near-term priorities amidst a challenging operating environment.”

Chuck MacFarlane, CEO

“The fundamentals of our diversified portfolio remain strong, and we are confident in our ability to deliver on our strategic growth plan over the long-term.”

Chuck MacFarlane, CEO
9:16 AM ET 8-K
Financial Results Fusemachines Inc. FUSE

Fusemachines Financial Results

Fusemachines Inc. reported Q3 2026 financial results featuring a 2.8% quarter-over-quarter revenue increase to $1.85 million and a 39.2% improvement in Adjusted EBITDA loss. Despite operational improvements from cost-reduction initiatives, the company reported a GAAP net loss of $4.6 million and disclosed substantial doubt about its ability to continue as a going concern.

Term
Q3 2026

“Our 39.2% quarter-over-quarter improvement in our Adjusted EBITDA demonstrates the meaningful progress we are making in improving the financial and operational performance of Fusemachines. Our cost-reduction initiatives are delivering measurable results, allowing us to significantly reduce operating losses while continuing to grow revenue. We remain focused on building a more efficient operating structure, strengthening our financial position, and advancing our enterprise AI business.”

Sameer Maskey, Founder and Chief Executive Officer of Fusemachines
9:15 AM ET 8-K
M&A Deal Impact Biomedical Inc. IBO

Impact Biomedical M&A Deal with Zoar Limited

Impact Biomedical Inc. announced that the SEC has declared effective the Form F-4 registration statement for its proposed merger with Zoar Limited. A special meeting of stockholders to approve the business combination is scheduled for November 13, 2026, with the combined company expected to trade under the ticker symbol 'ZOAR'.

Counterparty
Zoar Limited
9:15 AM ET 8-K
Financial Results BayFirst Financial Corp. BAFN

BayFirst Financial Financial Results

BayFirst Financial Corp. reported a net loss of $677 thousand for the third quarter of 2026, a significant improvement from the $32.7 million loss in the prior quarter. The company saw community bank loans grow by 25% and completed a rights offering that raised over $14 million in incremental capital.

Term
Q3 2026

“BayFirst is being transformed into the strong community bank that I've spoken about. ... While we still have work to do to deliver positive earnings in the short term, these accomplishments set the stage for that success. The earnings loss we report for the quarter is not indicative of what we will do going forward.”

Alfred T. Rogers, President, CEO & Director

“We are reporting a net loss of $677 thousand for the third quarter. This compares to the net loss of $32.7 million that we reported in the second quarter.”

Scott J. McKim, Executive VP & CFO
9:11 AM ET 8-K
Loan & Debt Indivior Pharmaceuticals, Inc. SUPN

Supernus Debt Financing Update with U.S. Bank Trust Company, National Association

Supernus, Inc. announced an adjustment to the conversion rate for its 0.625% Convertible Senior Notes due 2031 following a previously declared special dividend. The conversion rate increased from 24.0033 to 30.9355 shares per $1,000 principal amount, resulting in a new conversion price of approximately $32.33 per share.

Counterparty
U.S. Bank Trust Company, National Association
9:11 AM ET 10-Q
Financial Results Madrigal Pharmaceuticals, Inc. MDGL

Madrigal Pharmaceuticals Q3 2026 Results: Turns Profitable, Net Income $55.4M

Madrigal Pharmaceuticals reported a significant increase in net product revenue to $431.3 million for the third quarter of 2026, resulting in a quarterly net income of $55.4 million compared to a net loss in the prior year. For the nine months ended September 30, 2026, the company maintained a net loss of $96.9 million as it continues to scale commercial operations for Rezdiffra.

Key figure
Net income $55.4M
9:09 AM ET 8-K
Loan & Debt Geospace Technologies Corp GEOS

Geospace Technologies $25M Debt Financing with Amerisource Funding, Inc.

Geospace Technologies entered into a new $25 million revolving credit facility with Amerisource Funding, Inc. to refinance its existing debt and provide working capital. The new three-year agreement replaces a previous $25 million facility with Woodforest National Bank, which was terminated concurrently with the closing.

Value
$25M
Counterparty
Amerisource Funding, Inc.
Term
3 years
9:02 AM ET 10-Q
Financial Results Ichor Holdings, Ltd. ICHR

Ichor Holdings Q3 2026 Results: Turns Profitable, Net Income $20.9M

Ichor Holdings reported a significant recovery in the third quarter of 2026, with net sales increasing to $328.7 million compared to $239.3 million in the prior year period. The company achieved a net income of $20.9 million for the quarter, a substantial improvement from the $22.9 million net loss reported in Q3 2025, driven by higher gross margins and increased demand.

Key figure
Net income $20.9M
9:01 AM ET 8-K
Contract Win Cenntro Inc. CENN

Cenntro Wins $2.44M Contract from New York Truck Voucher Incentive Program

Cenntro Inc. delivered 20 LS450 electric trucks under the New York Truck Voucher Incentive Program (NYTVIP), generating over $2.44 million in revenue. The company is also expanding its participation in other state-level incentive programs in California and New Jersey to drive further adoption of its commercial electric vehicles.

Value
$2.44M
Counterparty
New York Truck Voucher Incentive Program (NYTVIP)
9:01 AM ET 10-Q
Financial Results Talen Energy Corp TLN

Talen Energy Q3 2026 Results: Net Income $138M, Down 33.3% YoY

Talen Energy reported a significant increase in operating revenues for the nine months ended September 30, 2026, reaching $3,203 million compared to $1,832 million in the prior year period. Despite higher revenues, net income attributable to stockholders decreased to $109 million from $144 million year-over-year, primarily driven by higher energy expenses and a $507 million unrealized loss on derivative instruments.

Key figure
Net income $138M · -33.3% YoY
9:01 AM ET 8-K
Stock Buyback PTC Therapeutics, Inc. PTCT

PTC Therapeutics Announces $500M Stock Buyback

PTC Therapeutics announced that its Board of Directors has authorized a share repurchase program to buy back up to $500 million of its common stock. The repurchases will be conducted at management's discretion through open-market or privately negotiated transactions based on market conditions.

Value
$500M
9:00 AM ET Form 4
Insider Buying TPG RE Finance Trust, Inc. TRTX

TPG RE Finance Trust Director Michael Bradley Smith Buys $32.6K of Stock

Michael Bradley Smith, Director, bought 5,000 shares of TPG RE Finance Trust, Inc. at $6.52 a share, worth $32.6K in total on Oct 30, 2026. Shares held after the trade: 105,223 (+5.0%).

Value
$32.6K
Shares
5,000
Price
$6.52
Role
Director
Holding change
+5.0%
Trade date
Oct 30, 2026
9:00 AM ET Form 4
Insider Buying TPG RE Finance Trust, Inc. TRTX

TPG RE Finance Trust Director Michael Gillmore Buys $12.9K of Stock

Michael Gillmore, Director, bought 2,000 shares of TPG RE Finance Trust, Inc. at $6.43 a share, worth $12.9K in total on Oct 30, 2026. Shares held after the trade: 2,500 (+400.0%).

Value
$12.9K
Shares
2,000
Price
$6.43
Role
Director
Holding change
+400.0%
Trade date
Oct 30, 2026
9:00 AM ET Form 4
Insider Buying TPG RE Finance Trust, Inc. TRTX

TPG RE Finance Trust Director Wendy Silverstein Buys $253K of Stock

Wendy Silverstein, Director, bought 38,900 shares of TPG RE Finance Trust, Inc. at $6.51 a share, worth $253K in total on Oct 30, 2026. Shares held after the trade: 38,900.

Value
$253K
Shares
38,900
Price
$6.51
Role
Director
Trade date
Oct 30, 2026
8:56 AM ET 10-Q
Financial Results DigitalOcean Holdings, Inc. DOCN ▶ Call

DigitalOcean Holdings Q3 2026 Results: Net Loss of $42.6M

DigitalOcean reported revenue of $321.2 million for Q3 2026, a significant increase from $229.6 million in the prior year, though it swung to a net loss of $42.6 million due to a $57.1 million induced conversion expense. The company's balance sheet shows a substantial increase in property and equipment to $1.4 billion, reflecting investments in its agentic inference cloud platform.

Key figure
Net loss $42.6M
8:56 AM ET 8-K
Contract Win SurgePays, Inc. SURG

SurgePays Wins $48M Contract from Zulie Venture Inc.

SurgePays entered into a material prepaid wireless purchase commitment with Etime system, which operates a payments network of over 1,000 retail locations. Etime system has committed to purchase at least $4 million in prepaid wireless airtime and top-up transactions monthly, totaling a minimum of $48 million over the initial one-year term.

Value
$48M
Counterparty
Zulie Venture Inc. (dba Etime system)
Term
1 year (Oct 2026 - Sept 2027)
8:53 AM ET 10-Q
Financial Results Amalgamated Financial Corp. AMAL

Amalgamated Financial Q3 2026 Results: Net Income $36.4M, Up 36.0% YoY

Amalgamated Financial Corp. reported total assets of approximately $9.65 billion as of September 30, 2026, reflecting growth in its loan portfolio and available-for-sale securities. The company maintained 29,704,953 shares of common stock outstanding and is classified as an accelerated filer.

Key figure
Net income $36.4M · +36.0% YoY
8:47 AM ET Form 4
Insider Selling Ebay Inc EBAY

Ebay VP, CAO Rebecca Spencer Sells $288K of Stock

Rebecca Spencer, VP, CAO, sold 2,366 shares of Ebay Inc at $121.86 a share, worth $288K in total on Oct 30, 2026. Shares held after the trade: 9,581 (-19.8%).

Value
$288K
Shares
2,366
Price
$121.86
Role
VP, CAO
Holding change
-19.8%
Trade date
Oct 30, 2026
8:47 AM ET 8-K
Financial Results Aptiv PLC APTV

Aptiv Financial Results

Aptiv PLC reported record third quarter 2026 revenues of $3.2 billion, a 2% increase year-over-year, driven by strong growth in non-automotive sectors and North American markets. The company achieved adjusted net income per share of $1.42 and generated $194 million in free cash flow during the period.

Term
Q3 2026

“During the third quarter, we delivered solid financial results and continued to execute against our strategic priorities. Our differentiated portfolio, backed by a resilient supply chain, continues to deliver performance and cost benefits for customers in a changing macro environment. Strong non-automotive revenue and bookings growth reflects the applicability of our products and capabilities across new and existing end markets. Through operational execution and disciplined capital allocation, we remain focused on investing in long-term growth and delivering on our commitment to prioritize returning capital to shareholders.”

Kevin Clark, chair and chief executive officer
8:46 AM ET 10-Q
Financial Results Chegg, Inc CHGG

Chegg Q3 2026 Results: Net Loss of $4.69M, Loss Narrows

Chegg, Inc. reported a significant decline in net revenues to $161.6 million for the nine months ended September 30, 2026, compared to $304.2 million in the prior year. Despite the revenue drop, the company narrowed its net loss to $7.4 million for the same period, down from a $70.6 million loss in 2025, primarily through substantial reductions in operating expenses.

Key figure
Net loss $4.69M
8:46 AM ET 8-K
Executive Compensation Beacon Financial Corp BBT

Beacon Financial Executive Compensation

Beacon Financial Corporation entered into a formal employment agreement with Sean A. Gray following his appointment as President and CEO. The agreement provides for an annual base salary of $1,000,000, a target annual cash bonus of 75% of base salary, and a one-time restricted stock award valued at $275,000.

Counterparty
Sean A. Gray
8:45 AM ET 8-K
Capital Raise Aeon Biopharma, Inc. AEON

Aeon Biopharma Capital Raise of $6.2M

AEON Biopharma entered into a warrant amendment to reduce the exercise price of its outstanding two-year milestone warrants from $0.3221 to $0.20 per share. Certain holders have agreed to exercise their warrants at this reduced price, which is expected to generate approximately $6.2 million in gross proceeds for the company. The warrants were triggered for accelerated expiration following FDA feedback on the company's ABP-450 biosimilar pathway and will expire on November 16, 2026.

Value
$6.2M
8:42 AM ET 8-K
Regulatory Approval Viking Global Technologies, Inc. VGTK

Viking Global Technologies Regulatory Approval

Viking Global Technologies' subsidiary, Viking Ozone Technology, received formal Attestation of Conformity No. 41506-0 from the French regulator LNE for its VKIN-300 medical waste pretreatment system. The approval confirms the ozone-based disinfection technology complies with French Standard NF X 30-503-1:2024, enabling commercialization of the system in France through October 2031.

Counterparty
Laboratoire national de métrologie et d'essais (LNE)
Term
5 years

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.